Corrigendum to “Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes” [Metabol Open. 2026, 29, 100453]
Corrigendum to “Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes” [Metabol Open. 2026, 29, 100453]. // Metabolism Open. – URL: https://www.sciencedirect.com/science/article/pii/S2589936826000800?dgcid=rss_sd_all
Corrigendum to “Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes” [Metabol Open. 2026, 29, 100453]. Metabolism Open. https://www.sciencedirect.com/science/article/pii/S2589936826000800?dgcid=rss_sd_all
“Corrigendum to “Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes” [Metabol Open. 2026, 29, 100453].” Metabolism Open.
@article{article58761,
title = {Corrigendum to “Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes” [Metabol Open. 2026, 29, 100453]},
journal = {Metabolism Open},
url = {https://www.sciencedirect.com/science/article/pii/S2589936826000800?dgcid=rss_sd_all}
}